Inivata Ltd.
Liquid biopsies for cancer
This article was originally published in Start Up
Executive Summary
UK-based start-up Inivata Ltd. is using cell-free circulating tumor DNA (ctDNA), found in the bloodstream, to create a “liquid biopsy.” This has potential to make cancer diagnosis and testing less invasive for patients, enhance monitoring to track response to treatment of the disease, improve the treatment decision process for physicians, and support clinical trial design, potentially speeding new drugs to the market.